Highlights Genetic Analysis

Equities

GEAN

NO0010692130

End-of-day quote NORDIC GROWTH MARKET Other stock markets 03:30:00 27/06/2024 am IST			5-day change	1st Jan Change
0.66 ^NOK	-5.71%		-11.05%	-22.35%

06/06	Genetic Analysis as Announces Resignation of Eilert Aamodt as Chief Financial Officer	CI
29/05	Genetic Analysis AS Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Genetic Analysis AS Reports Earnings Results for the First Quarter Ended March 31, 2024	29/05	CI
Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29/02	CI
Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit	26/02	CI
Genetic Analysis Partners Up to Enter the Consumer Market with Ga-Map	21/12	CI
Genetic Analysis AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11	CI
Genetic Analysis AS Provides Earnings Guidance for the Year 2023, 2024, and 2025	03/11	CI
Genetic Analysis AS Launches the GA-map® Discovery - New Microbiome Profiling Service Offering Directed to Research Customers in the Academia and Microbiome Industry	24/23/24	CI
Genetic Analysis AS Announces Development Project Initiated for A New Companion Diagnostic Test	12/23/12	CI
Genetic Analysis AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/23/30	CI
Genetic Analysis Secures Partnership Deal for US Launch of GA-map Microbiome Test	25/23/25	MT
Genetic Analysis AS Enters an Agreement with Elta90 Group to Distribute and Launch Ga-Map[®] Technology in the Balkan Region	08/23/08	CI
Genetic Analysis AS Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	17/23/17	CI
Genetic Analysis Wins Approval for Gut Microbiome Test in Thailand	19/23/19	MT
Genetic Analysis as Achieves Thai Fda License for Ga-Map[®] Dysbiosis Test in Thailand	19/23/19	CI
Genetic Analysis Strikes Distribution Deal For Gut Microbiota Test In Europe	07/22/07	MT
Genetic Analysis as Enters an Agreement with A Major Diagnostic Company for Distribution of GA-map in Europe	07/22/07	CI
Genetic Analysis AS Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/22/01	CI
Genetic Analysis AS Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	18/22/18	CI
Genetic Analysis and Servatus Enter Strategic Collaboration Agreement to Develop New Microbiome Diagnostostic and Therapeutic Solutions	22/22/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Genetic Analysis

Equities

GEAN

NO0010692130

Highlights

Filters